US Stock MarketDetailed Quotes

NFH.WS NEW FRONTIER HEALTH CORPORATION C/WTS 30/11/2024 (TO PUR COM)

Watchlist

0.000
0.0000.00%

Close Jan 8 09:30 ET

0Market Cap0.00P/E (TTM)

NEW FRONTIER HEALTH CORPORATION C/WTS 30/11/2024 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

(Q2)Jun 30, 2020

(Q1)Mar 31, 2020

(FY)Dec 18, 2019

(Q4)Dec 18, 2019

(Q3)Sep 30, 2019

(Q2)Jun 30, 2019

(Q1)Mar 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-16.24%265.22M

141.75%316.64M

Net income from continuing operations

-215.18%-504.15M

----

-69.63%-159.95M

----

Operating gains losses

1,067.30%161.59M

----

-59.93%13.84M

----

Depreciation and amortization

29.05%425.16M

----

137.63%329.45M

----

Other non cash items

93.41%252.42M

----

1,466.35%130.51M

----

Change In working capital

113.63%142.05M

----

-40.21%66.5M

----

-Change in receivables

115.92%22.59M

----

-1,159.50%-141.96M

----

-Change in inventory

-5,863.50%-35.78M

----

96.57%-600K

----

-Change in payables and accrued expense

-227.87%-231.28M

----

29.86%180.87M

----

-Change in other working capital

1,271.27%386.52M

----

3,938.25%28.19M

----

Cash from discontinued investing activities

Operating cash flow

-16.24%265.22M

85.32%67.13M

-52.56%48.55M

421.19%386.56M

-328.08%-237.02M

141.75%316.64M

2,522.18%36.22M

6,766.90%102.33M

3,224,806.39%74.17M

--103.92M

Investing cash flow

Cash flow from continuing investing activities

6.46%-319.69M

36.11%-341.77M

Net PPE purchase and sale

8.25%-309.46M

----

34.88%-337.29M

----

Net intangibles purchase and sale

21.20%-3.53M

----

64.69%-4.48M

----

Net business purchase and sale

---6.7M

----

--0

----

Cash from discontinued investing activities

Investing cash flow

6.46%-319.69M

-111.07%-104.16M

21.52%-88.3M

-286.15%-112.61M

90.30%-14.63M

36.11%-341.77M

-8,981.57%-49.35M

94.31%-112.51M

---29.16M

---150.76M

Financing cash flow

Cash flow from continuing financing activities

-232.30%-631.23M

-283.30%-189.96M

Net issuance payments of debt

-247.86%-660.79M

----

-283.30%-189.96M

----

Net other financing activities

--29.56M

----

Cash from discontinued financing activities

Financing cash flow

-232.30%-631.23M

-226.23%-57.83M

37.47%-43.54M

-968.65%-476.77M

8.45%-53.1M

-283.30%-189.96M

-2,971.27%-17.73M

-103.52%-69.63M

-338.55%-44.61M

---58M

Net cash flow

Beginning cash position

126.83%1.35B

----

-33.11%596.61M

----

Current changes in cash

-218.80%-685.71M

----

28.38%-215.09M

----

Effect of exchange rate changes

-581.44%-27.16M

----

12.08%5.64M

----

End cash Position

65.42%640.43M

----

-35.11%387.16M

----

Free cash flow

-90.10%-47.78M

19.53%-245.86M

-52.56%48.55M

421.19%386.56M

-328.08%-237.02M

93.71%-25.13M

-20,332.20%-305.55M

6,766.90%102.33M

3,224,806.39%74.17M

--103.92M

Currency Unit

CNY

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020	(Q2)Jun 30, 2020	(Q1)Mar 31, 2020	(FY)Dec 18, 2019	(Q4)Dec 18, 2019	(Q3)Sep 30, 2019	(Q2)Jun 30, 2019	(Q1)Mar 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-16.24%265.22M					141.75%316.64M
Net income from continuing operations	-215.18%-504.15M	----	----	----	----	-69.63%-159.95M	----	----	----	----
Operating gains losses	1,067.30%161.59M	----	----	----	----	-59.93%13.84M	----	----	----	----
Depreciation and amortization	29.05%425.16M	----	----	----	----	137.63%329.45M	----	----	----	----
Other non cash items	93.41%252.42M	----	----	----	----	1,466.35%130.51M	----	----	----	----
Change In working capital	113.63%142.05M	----	----	----	----	-40.21%66.5M	----	----	----	----
-Change in receivables	115.92%22.59M	----	----	----	----	-1,159.50%-141.96M	----	----	----	----
-Change in inventory	-5,863.50%-35.78M	----	----	----	----	96.57%-600K	----	----	----	----
-Change in payables and accrued expense	-227.87%-231.28M	----	----	----	----	29.86%180.87M	----	----	----	----
-Change in other working capital	1,271.27%386.52M	----	----	----	----	3,938.25%28.19M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-16.24%265.22M	85.32%67.13M	-52.56%48.55M	421.19%386.56M	-328.08%-237.02M	141.75%316.64M	2,522.18%36.22M	6,766.90%102.33M	3,224,806.39%74.17M	--103.92M
Investing cash flow
Cash flow from continuing investing activities	6.46%-319.69M					36.11%-341.77M
Net PPE purchase and sale	8.25%-309.46M	----	----	----	----	34.88%-337.29M	----	----	----	----
Net intangibles purchase and sale	21.20%-3.53M	----	----	----	----	64.69%-4.48M	----	----	----	----
Net business purchase and sale	---6.7M	----	----	----	----	--0	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	6.46%-319.69M	-111.07%-104.16M	21.52%-88.3M	-286.15%-112.61M	90.30%-14.63M	36.11%-341.77M	-8,981.57%-49.35M	94.31%-112.51M	---29.16M	---150.76M
Financing cash flow
Cash flow from continuing financing activities	-232.30%-631.23M					-283.30%-189.96M
Net issuance payments of debt	-247.86%-660.79M	----	----	----	----	-283.30%-189.96M	----	----	----	----
Net other financing activities	--29.56M	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-232.30%-631.23M	-226.23%-57.83M	37.47%-43.54M	-968.65%-476.77M	8.45%-53.1M	-283.30%-189.96M	-2,971.27%-17.73M	-103.52%-69.63M	-338.55%-44.61M	---58M
Net cash flow
Beginning cash position	126.83%1.35B	----	----	----	----	-33.11%596.61M	----	----	----	----
Current changes in cash	-218.80%-685.71M	----	----	----	----	28.38%-215.09M	----	----	----	----
Effect of exchange rate changes	-581.44%-27.16M	----	----	----	----	12.08%5.64M	----	----	----	----
End cash Position	65.42%640.43M	----	----	----	----	-35.11%387.16M	----	----	----	----
Free cash flow	-90.10%-47.78M	19.53%-245.86M	-52.56%48.55M	421.19%386.56M	-328.08%-237.02M	93.71%-25.13M	-20,332.20%-305.55M	6,766.90%102.33M	3,224,806.39%74.17M	--103.92M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Heat List

Overall

No Data